DUSP9 and neoplasm: However, DUSP9 knockdown in MHCC‐97H cells (MHCC‐97H‐shDUSP9) reduced tumourigenicity, with delayed tumour formation, smaller tumour size and lower tumour incidence compared to the control group (MHCC‐97H‐shNC; Figure 6E–H,J).